Motor Imagery and Functional Performance in Diplegic Cerebral Palsy

Investigation of the Relationship Between Motor Imagery Ability and Functional Mobility, Walking, and Balance in Children With Diplegic Cerebral Palsy

The main purpose of this study was to examine the relationship between motor imagery capacity and functional mobility, walking and balance in children with diplegic type cerebral palsy.

Study Overview

• Status: Recruiting
• Conditions: Diplegic Cerebral Palsy With Spasticity; Motor İmagery Ability
• Intervention / Treatment: Other: Motor Imagery Ability Assessment; Other: Mental Stopwatch Paradigm; Other: Functional Mobility; Other: Gait assessment:

Detailed Description

This study will be conducted using a cross-sectional and correlational screening model to examine the relationship between motor imagery ability and functional mobility, walking, and balance in children with diplegic cerebral palsy. Data collection will be conducted through one-on-one assessments after obtaining written consent from volunteer participants and their families. The data collection tools used in the study are listed below: Demographic Information Form, Motor Imagery Ability Assessment, Mental Stopwatch Paradigm, Functional Mobility, and Gait Assessment.

• Study Type: Observational
• Enrollment (Estimated): 99

Contacts and Locations

• Study Contact: Name: dilan demirtas karaoba, asst. prof, asst. prof; Phone Number: +905541127796; Email: dilandemirtas92@gmail.com

Study Locations

• Turkey (Türkiye)
  • Bingöl, Turkey (Türkiye)
    • Recruiting
    • Bingöl
    • Contact: Büşra Candiri, asst. prof; Phone Number: 0 507 378 07 17; Email: busracandiri@gmail.com
    • Contact: Hasan BİNGÖL, asst. prof; Phone Number: +90 507 232 81 00

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

diplegic cerebral palsy

Description

Inclusion Criteria:

• Diagnosed with diplegic CP by a neurologist or pediatric neurologist
• Being between 5 and 18 years of age
• Being between levels I and III on the GMFCS
• Having the cognitive ability to follow the assessment instructions
• Informed consent form has been obtained from the child's family
• The child has agreed to participate voluntarily in the study

Exclusion Criteria:

• Having severe impairments in basic sensory systems such as vision or hearing
• Having additional diagnoses such as epilepsy or autism spectrum disorder
• Demonstrating cognitive or behavioral problems that prevent them from following instructions during the assessment
• Having informed consent from the child's family or the child

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Mental Stopwatch Paradigm	A mental stopwatch will be used to assess explicit MI capacity. This paradigm compares the time between the actual movement duration and the duration of a similar imagined task.	24-48 hours
Laterality Task (Choice Task):	Laterality Task (Choice Task): Implicit Motor Imagery capacity will be measured through a laterality task, which involves deciding which side a limb belongs to. Right-left discrimination of the foot will be assessed using the "Recognize Foot" application developed by the Neuro Orthopaedic Institute	24-48 hours
Functional Mobility using the Functional Mobility Scale (FMS)	Functional Mobility: Functional Mobility will be assessed using the Functional Mobility Scale (FMS)	24-48 hours
Functional Mobility using the Timed Up and Go test	Functional Mobility: Functional Mobility will be assessed using the Timed Up and Go test.	24-48 hours
The Gillette Functional Assessment Questionnaire	Gait assessment: The Gillette Functional Assessment Questionnaire is a self- or observer-based assessment tool, minimum score 22 maximum score 88	24-48 hours

Collaborators and Investigators

• Sponsor: Inonu University

Study record dates

Study Major Dates

• Study Start (Actual): November 24, 2025
• Primary Completion (Estimated): February 23, 2026
• Study Completion (Estimated): February 26, 2026

Study Registration Dates

• First Submitted: December 2, 2025
• First Submitted That Met QC Criteria: December 16, 2025
• First Posted (Actual): December 17, 2025

Study Record Updates

• Last Update Posted (Actual): December 17, 2025
• Last Update Submitted That Met QC Criteria: December 16, 2025
• Last Verified: December 1, 2025

More Information

Terms related to this study

• Other Study ID Numbers: 2025/0725

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No